NEURONOSTICS LIMITED

Active Bristol

Other research and experimental development on natural sciences and engineering

13 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
N

NEURONOSTICS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 22 Dec 2017 Active Bristol, England 13 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 31 Mar 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 28 Dec 2025 Next due 22 Dec 2026 6 months remaining
Net assets £730K £25K 2024 year on year
Total assets £832K £9K 2024 year on year
Total Liabilities £102K £16K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Engine Shed Station Approach Bristol BS1 6QH England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for NEURONOSTICS LIMITED (11123728), an active life sciences and medical technology company based in Bristol, England. Incorporated 22 Dec 2017. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2018–2024)

Cash in Bank

£386.20k

Decreased by £347.56k (-47%)

Net Assets

£730.49k

Decreased by £24.51k (-3%)

Total Liabilities

£101.74k

Increased by £15.98k (+19%)

Turnover

£104.39k

Employees

13

Increased by 2 (+18%)

Debt Ratio

12%

Increased by 2 (+20%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 3

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 3Jan 2018Bridge/Convertible
Investor 4Mar 2021Pre-Seed
Investor 5Mar 2021Pre-Seed, Seed

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 1,151,212 Shares £4.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Mar 2026290,635£1.02m£3.5
26 Mar 2026414,529£1.45m£3.5
14 Jul 202523,316£2.332£0
28 Mar 202452,636£163k£3.09
8 Mar 202485,288£264k£3.09

Officers

Officers

1 active 2 resigned
Status
David BullerDirectorBritishEngland5222 Jun 2023Active

Shareholders

Shareholders (22)

Professor John Terry
22.4%
412,500
Mr Wessel Woldman
16.1%
297,400

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Professor John Terry

Ceased 3 Apr 2023

Ceased

Wessel Woldman

Ceased 30 Apr 2021

Ceased

Martin Brown

Ceased 18 Jun 2018

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Apr 2026CapitalAllotment of shares (GBP 254.7806) on 31 Mar 2026
25 Mar 2026IncorporationMemorandum Articles
25 Mar 2026ResolutionResolutions
28 Dec 2025Confirmation StatementConfirmation statement made on 8 Dec 2025 with updates
24 Dec 2025OfficersAppointment of Mr Charles Edward Alvarez as director
24 Apr 2026 Capital

Allotment of shares (GBP 254.7806) on 31 Mar 2026

25 Mar 2026 Incorporation

Memorandum Articles

25 Mar 2026 Resolution

Resolutions

28 Dec 2025 Confirmation Statement

Confirmation statement made on 8 Dec 2025 with updates

24 Dec 2025 Officers

Appointment of Mr Charles Edward Alvarez as director

Recent Activity

Latest Activity

Allotment of shares (GBP 254.7806) on 31 Mar 2026

1 months ago on 24 Apr 2026

Memorandum Articles

2 months ago on 25 Mar 2026

Resolutions

2 months ago on 25 Mar 2026

Confirmation statement made on 8 Dec 2025 with updates

5 months ago on 28 Dec 2025

Appointment of Mr Charles Edward Alvarez as director

5 months ago on 24 Dec 2025